Hidrasec Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Racecadotril

Indications/Uses

Complementary, symptomatic treatment of acute diarrhoea in infants (>3 mth) & childn when oral rehydration & usual support measures are insufficient to control the clinical condition.

Click to view Hidrasec detailed prescribing information

Dosage/Direction for Use

Recommended dose: 1.5 mg/kg/dose (corresponding to 1-2 sachets) tds. Childn >27 kg Two 30 mg tds; 13-27 kg One 30 mg tds; infant 9 to <13 kg Two 10 mg tds; <9 kg One 10 mg tds. Treatment should be continued until 2 normal stools are recorded. Treatment should not exceed 7 days.

Click to view Hidrasec detailed prescribing information

Overdosage

View Hidrasec overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food: May be mixed w/ food or dispersed in a glass of water or into a feeding-bottle. Mix thoroughly & take immediately after prep.

Contraindications

Hypersensitivity. Patients who have reported angioedema w/ ACE inhibitors (eg, captopril, enalapril, lisinopril, perindopril, ramipril). Fructose intolerance, glucose-galactose malabsorption syndrome or sucrase-isomaltase insufficiency.

Click to view Hidrasec detailed prescribing information

Special Precautions

Monitor regular feeding (including breastfeeding) & adequate fluid intake. Do not administer in the presence of bloody or purulent stool & fever. Not recommended in antibiotic-associated diarrhoea & chronic diarrhoea. Diabetes. Do not administer in cases of prolonged or uncontrolled vomiting. Stop immediately when experiencing severe skin reactions. Hypersensitivity/angioedema may occur at any time during therapy. Patients w/ history of angioedema unrelated to racecadotril therapy may be at increased risk of angioedema. Childn w/ renal or liver impairment. Do not administer in infant <3 mth.

Click to view Hidrasec detailed prescribing information

Use In Pregnancy & Lactation

Click to view Hidrasec detailed prescribing information

Adverse Reactions

Uncommon: Tonsilitis; rash, erythema.

Click to view Hidrasec detailed prescribing information

Drug Interactions

Increase risk of angioedema w/ ACE inhibitors (eg, captopril, enalapril, lisinopril, fosinopril, perindopril, ramipril).

Click to view Hidrasec detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Hidrasec detailed prescribing information

Storage

View Hidrasec storage conditions for details to ensure optimal shelf-life.

Description

View Hidrasec description for details of the chemical structure and excipients (inactive components).

Action

View Hidrasec mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antidiarrheals

ATC Classification

A07XA04 - racecadotril ; Belongs to the class of other antidiarrheals.

Regulatory Classification

POM

Presentation/Packing

Form

Hidrasec Infant granules for oral susp 10 mg

Packing/Price

16 × 1's

Form

Hidrasec Children granules for oral susp 30 mg

Packing/Price

16 × 1's

Hidrasec

racecadotril

Manufacturer:

Abbott

Distributor:

Zuellig Pharma